Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine

Different mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected host cell factors to enable virus replication. The viral genomic RNA of the human immunodeficiency virus (HIV) encompasses nine genes encoding in less than 10 kb all proteins needed for replication in suscepti...

Full description

Bibliographic Details
Main Authors: Yasemin van Heuvel, Stefanie Schatz, Jamila Franca Rosengarten, Jörn Stitz
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/14/2/138
_version_ 1827652434693980160
author Yasemin van Heuvel
Stefanie Schatz
Jamila Franca Rosengarten
Jörn Stitz
author_facet Yasemin van Heuvel
Stefanie Schatz
Jamila Franca Rosengarten
Jörn Stitz
author_sort Yasemin van Heuvel
collection DOAJ
description Different mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected host cell factors to enable virus replication. The viral genomic RNA of the human immunodeficiency virus (HIV) encompasses nine genes encoding in less than 10 kb all proteins needed for replication in susceptible host cells. To do so, the genomic RNA undergoes complex alternative splicing to facilitate the synthesis of the structural, accessory, and regulatory proteins. However, HIV strongly relies on the host cell machinery recruiting cellular factors to complete its replication cycle. Antiretroviral therapy (ART) targets different steps in the cycle, preventing disease progression to the acquired immunodeficiency syndrome (AIDS). The comprehension of the host immune system interaction with the virus has fostered the development of a variety of vaccine platforms. Despite encouraging provisional results in vaccine trials, no effective vaccine has been developed, yet. However, novel promising vaccine platforms are currently under investigation.
first_indexed 2024-03-09T20:55:25Z
format Article
id doaj.art-5c7d361651e4436ab2ca69930536b16d
institution Directory Open Access Journal
issn 2072-6651
language English
last_indexed 2024-03-09T20:55:25Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj.art-5c7d361651e4436ab2ca69930536b16d2023-11-23T22:21:59ZengMDPI AGToxins2072-66512022-02-0114213810.3390/toxins14020138Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a VaccineYasemin van Heuvel0Stefanie Schatz1Jamila Franca Rosengarten2Jörn Stitz3Research Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyResearch Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyResearch Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyResearch Group Pharmaceutical Biotechnology, Faculty of Applied Natural Sciences, TH Köln—University of Applied Sciences, Chempark Leverkusen, Kaiser-Wilhelm-Allee, 51368 Leverkusen, GermanyDifferent mechanisms mediate the toxicity of RNA. Genomic retroviral mRNA hijacks infected host cell factors to enable virus replication. The viral genomic RNA of the human immunodeficiency virus (HIV) encompasses nine genes encoding in less than 10 kb all proteins needed for replication in susceptible host cells. To do so, the genomic RNA undergoes complex alternative splicing to facilitate the synthesis of the structural, accessory, and regulatory proteins. However, HIV strongly relies on the host cell machinery recruiting cellular factors to complete its replication cycle. Antiretroviral therapy (ART) targets different steps in the cycle, preventing disease progression to the acquired immunodeficiency syndrome (AIDS). The comprehension of the host immune system interaction with the virus has fostered the development of a variety of vaccine platforms. Despite encouraging provisional results in vaccine trials, no effective vaccine has been developed, yet. However, novel promising vaccine platforms are currently under investigation.https://www.mdpi.com/2072-6651/14/2/138retrovirusesHIVvirus replicationmRNA splicingantiretroviral therapy (ART)HIV vaccines
spellingShingle Yasemin van Heuvel
Stefanie Schatz
Jamila Franca Rosengarten
Jörn Stitz
Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
Toxins
retroviruses
HIV
virus replication
mRNA splicing
antiretroviral therapy (ART)
HIV vaccines
title Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
title_full Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
title_fullStr Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
title_full_unstemmed Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
title_short Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
title_sort infectious rna human immunodeficiency virus hiv biology therapeutic intervention and the quest for a vaccine
topic retroviruses
HIV
virus replication
mRNA splicing
antiretroviral therapy (ART)
HIV vaccines
url https://www.mdpi.com/2072-6651/14/2/138
work_keys_str_mv AT yaseminvanheuvel infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine
AT stefanieschatz infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine
AT jamilafrancarosengarten infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine
AT jornstitz infectiousrnahumanimmunodeficiencyvirushivbiologytherapeuticinterventionandthequestforavaccine